Schedule 13G ownership disclosure

IMMUNOPRECISE ANTIBODIES LTD

Common Shares, no par value · CUSIP: 45257F200

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Charmquark TWEE

    Shares: 1,828,365 · Class: 5.8%

  • Charmquark EEN

    Shares: 1,828,365 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000912282-25-000055
Form type
SCHEDULE 13G/A
Filer
Charmquark TWEE
CIK
CIK 1930122
Filed
Jan 24, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub